Brigham J Hartley
Following the completion of honours at the Florey Neurosciences Institute where he studied the dimersiation of a group of neropeptide related GPCRs, Brigham Jay Hartley moved to the Stem Cell Biology Labarory within the Drug Discovery Biology Platform at Monash University Parkville. He is currently interested the generation of functional midbrain dopaminergic (mbDA) neurons from human pluripotent stem cells (hPSCs) using novel engineered reporter cell lines and small molecules biomimetics. This work is now moving towards the use of hPSC-derived mbDA neurons for in vitro modelling of Parkinson’s disease with a specific focus on the neuroinflammation associated with the degenerative process.
Abstracts this author is presenting: